| Date | Form | Description | Docs | XBRL | Pages |
| 06/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 03/17/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
47 | |
| 09/09/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
33 | |
| 06/18/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
30 | |
| 06/10/09 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 03/12/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 | |
| 09/19/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
39 | |
| 09/10/08 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 06/09/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 | |
| 03/12/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
76 |
Latest News & Events
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
Read More...Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
Read More...